- call +1-201-465-4211
- email sales@mrinsights.biz
Heart defect closure devices are permanent implants designed to close defects between chambers of the heart or a patent ductus arteriosus. These are self-expandable, self-centering umbrella-like devices. The design and shape of the devices vary, as does their exact mode of deployment. They are implanted in the defect in a cardiac catheterization laboratory, through catheters inserted into either a vein or an artery (transcatheter or percutaneous approach). There are several types of defects, which include atrial septal defect (ASD), persistent patent ductus arteriosus (PDA), ventricular septal defect (VSD), patent foramen ovale (PFO), and left atrial appendage (LAA). Most of these defects are congenital, but can occur after a myocardial infarction or can be the result of a surgical repair of other congenital heart defects.
The classification of Heart Defect Closure Devices includes ASD Closure Devices, VSD Closure Devices, PDA Closure Devices, PFO Closure Devices and LAA Closure Devices. And the proportion of Amplatzer PFO Occluder in 2017 is about 33%, and the proportion is in decreasing trend from 2013 to 2017. LAA Closure Devices with the growth rate about 18%, in 2017 the market share is nearly 22%.
Heart Defect Closure Devices is widely used in hospitals and clinics. The most proportion of Heart Defect Closure Devices is used in Hospital, and the proportion in 2017 is 61%. Europe is the largest consumption place, with a consumption market share nearly 30% in 2017. Following Europe, North America is the second largest consumption place with the consumption market share of 27%.
Market competition is not intense. Abbott, Boston Scientific, LifeTech, Lepu Medical, Occlutech, W. L. Gore & Associates and Starway are the leaders of the industry, with high-end customers.
According to this study, over the next five years the Heart Defect Closure Devices market will register a 9.3% CAGR in terms of revenue, the global market size will reach US$ 992.2 million by 2024, from US$ 635 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Heart Defect Closure Devices business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Heart Defect Closure Devices market by product type, application, key manufacturers and key regions and countries.
This study considers the Heart Defect Closure Devices value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
ASD Closure Devices
VSD Closure Devices
PDA Closure Devices
PFO Closure Devices
LAA Closure Devices
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Hospitals
Clinics
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Abbott
Boston Scientific
LifeTech
Lepu Medical
Occlutech
W. L. Gore and Associates
Starway
Coherex Medical
Cardia
MicroPort
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Heart Defect Closure Devices consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Heart Defect Closure Devices market by identifying its various subsegments.
Focuses on the key global Heart Defect Closure Devices manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Heart Defect Closure Devices with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Heart Defect Closure Devices submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
2019-2024 Global Heart Defect Closure Devices Consumption Market Report
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Heart Defect Closure Devices Consumption 2014-2024
2.1.2 Heart Defect Closure Devices Consumption CAGR by Region
2.2 Heart Defect Closure Devices Segment by Type
2.2.1 ASD Closure Devices
2.2.2 VSD Closure Devices
2.2.3 PDA Closure Devices
2.2.4 PFO Closure Devices
2.2.5 LAA Closure Devices
2.3 Heart Defect Closure Devices Consumption by Type
2.3.1 Global Heart Defect Closure Devices Consumption Market Share by Type (2014-2019)
2.3.2 Global Heart Defect Closure Devices Revenue and Market Share by Type (2014-2019)
2.3.3 Global Heart Defect Closure Devices Sale Price by Type (2014-2019)
2.4 Heart Defect Closure Devices Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.5 Heart Defect Closure Devices Consumption by Application
2.5.1 Global Heart Defect Closure Devices Consumption Market Share by Application (2014-2019)
2.5.2 Global Heart Defect Closure Devices Value and Market Share by Application (2014-2019)
2.5.3 Global Heart Defect Closure Devices Sale Price by Application (2014-2019)
3 Global Heart Defect Closure Devices by Manufacturers
3.1 Global Heart Defect Closure Devices Sales Market Share by Manufacturers
3.1.1 Global Heart Defect Closure Devices Sales by Manufacturers (2017-2019)
3.1.2 Global Heart Defect Closure Devices Sales Market Share by Manufacturers (2017-2019)
3.2 Global Heart Defect Closure Devices Revenue Market Share by Manufacturers
3.2.1 Global Heart Defect Closure Devices Revenue by Manufacturers (2017-2019)
3.2.2 Global Heart Defect Closure Devices Revenue Market Share by Manufacturers (2017-2019)
3.3 Global Heart Defect Closure Devices Sale Price by Manufacturers
3.4 Global Heart Defect Closure Devices Manufacturing Base Distribution, Sales Area, Product Types by Manufacturers
3.4.1 Global Heart Defect Closure Devices Manufacturing Base Distribution and Sales Area by Manufacturers
3.4.2 Players Heart Defect Closure Devices Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Heart Defect Closure Devices by Regions
4.1 Heart Defect Closure Devices by Regions
4.1.1 Global Heart Defect Closure Devices Consumption by Regions
4.1.2 Global Heart Defect Closure Devices Value by Regions
4.2 Americas Heart Defect Closure Devices Consumption Growth
4.3 APAC Heart Defect Closure Devices Consumption Growth
4.4 Europe Heart Defect Closure Devices Consumption Growth
4.5 Middle East & Africa Heart Defect Closure Devices Consumption Growth
5 Americas
5.1 Americas Heart Defect Closure Devices Consumption by Countries
5.1.1 Americas Heart Defect Closure Devices Consumption by Countries (2014-2019)
5.1.2 Americas Heart Defect Closure Devices Value by Countries (2014-2019)
5.2 Americas Heart Defect Closure Devices Consumption by Type
5.3 Americas Heart Defect Closure Devices Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Heart Defect Closure Devices Consumption by Countries
6.1.1 APAC Heart Defect Closure Devices Consumption by Countries (2014-2019)
6.1.2 APAC Heart Defect Closure Devices Value by Countries (2014-2019)
6.2 APAC Heart Defect Closure Devices Consumption by Type
6.3 APAC Heart Defect Closure Devices Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries
7 Europe
7.1 Europe Heart Defect Closure Devices by Countries
7.1.1 Europe Heart Defect Closure Devices Consumption by Countries (2014-2019)
7.1.2 Europe Heart Defect Closure Devices Value by Countries (2014-2019)
7.2 Europe Heart Defect Closure Devices Consumption by Type
7.3 Europe Heart Defect Closure Devices Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Heart Defect Closure Devices by Countries
8.1.1 Middle East & Africa Heart Defect Closure Devices Consumption by Countries (2014-2019)
8.1.2 Middle East & Africa Heart Defect Closure Devices Value by Countries (2014-2019)
8.2 Middle East & Africa Heart Defect Closure Devices Consumption by Type
8.3 Middle East & Africa Heart Defect Closure Devices Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Heart Defect Closure Devices Distributors
10.3 Heart Defect Closure Devices Customer
11 Global Heart Defect Closure Devices Market Forecast
11.1 Global Heart Defect Closure Devices Consumption Forecast (2019-2024)
11.2 Global Heart Defect Closure Devices Forecast by Regions
11.2.1 Global Heart Defect Closure Devices Forecast by Regions (2019-2024)
11.2.2 Global Heart Defect Closure Devices Value Forecast by Regions (2019-2024)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Heart Defect Closure Devices Forecast by Type
11.8 Global Heart Defect Closure Devices Forecast by Application
12 Key Players Analysis
12.1 Abbott
12.1.1 Company Details
12.1.2 Heart Defect Closure Devices Product Offered
12.1.3 Abbott Heart Defect Closure Devices Sales, Revenue, Price and Gross Margin (2017-2019)
12.1.4 Main Business Overview
12.1.5 Abbott News
12.2 Boston Scientific
12.2.1 Company Details
12.2.2 Heart Defect Closure Devices Product Offered
12.2.3 Boston Scientific Heart Defect Closure Devices Sales, Revenue, Price and Gross Margin (2017-2019)
12.2.4 Main Business Overview
12.2.5 Boston Scientific News
12.3 LifeTech
12.3.1 Company Details
12.3.2 Heart Defect Closure Devices Product Offered
12.3.3 LifeTech Heart Defect Closure Devices Sales, Revenue, Price and Gross Margin (2017-2019)
12.3.4 Main Business Overview
12.3.5 LifeTech News
12.4 Lepu Medical
12.4.1 Company Details
12.4.2 Heart Defect Closure Devices Product Offered
12.4.3 Lepu Medical Heart Defect Closure Devices Sales, Revenue, Price and Gross Margin (2017-2019)
12.4.4 Main Business Overview
12.4.5 Lepu Medical News
12.5 Occlutech
12.5.1 Company Details
12.5.2 Heart Defect Closure Devices Product Offered
12.5.3 Occlutech Heart Defect Closure Devices Sales, Revenue, Price and Gross Margin (2017-2019)
12.5.4 Main Business Overview
12.5.5 Occlutech News
12.6 W. L. Gore and Associates
12.6.1 Company Details
12.6.2 Heart Defect Closure Devices Product Offered
12.6.3 W. L. Gore and Associates Heart Defect Closure Devices Sales, Revenue, Price and Gross Margin (2017-2019)
12.6.4 Main Business Overview
12.6.5 W. L. Gore and Associates News
12.7 Starway
12.7.1 Company Details
12.7.2 Heart Defect Closure Devices Product Offered
12.7.3 Starway Heart Defect Closure Devices Sales, Revenue, Price and Gross Margin (2017-2019)
12.7.4 Main Business Overview
12.7.5 Starway News
12.8 Coherex Medical
12.8.1 Company Details
12.8.2 Heart Defect Closure Devices Product Offered
12.8.3 Coherex Medical Heart Defect Closure Devices Sales, Revenue, Price and Gross Margin (2017-2019)
12.8.4 Main Business Overview
12.8.5 Coherex Medical News
12.9 Cardia
12.9.1 Company Details
12.9.2 Heart Defect Closure Devices Product Offered
12.9.3 Cardia Heart Defect Closure Devices Sales, Revenue, Price and Gross Margin (2017-2019)
12.9.4 Main Business Overview
12.9.5 Cardia News
12.10 MicroPort
12.10.1 Company Details
12.10.2 Heart Defect Closure Devices Product Offered
12.10.3 MicroPort Heart Defect Closure Devices Sales, Revenue, Price and Gross Margin (2017-2019)
12.10.4 Main Business Overview
12.10.5 MicroPort News
13 Research Findings and Conclusion
List of Tables and Figures
Figure Picture of Heart Defect Closure Devices
Table Product Specifications of Heart Defect Closure Devices
Figure Heart Defect Closure Devices Report Years Con
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
